Intravesical Instillation of Azacitidine Suppresses Tumor Formation through TNF-R1 and TRAIL-R2 Signaling in Genotoxic Carcinogen-Induced Bladder Cancer

SIMPLE SUMMARY: Approximately 70% of all bladder cancer is diagnosed as non-muscle invasive bladder cancer and can be treated by transurethral resection of the bladder tumor, followed by intravesical instillation chemotherapy. Bacille Calmette-Guérin (BCG) is the first-line agent for intravesical in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shao-Chuan, Chang, Ya-Chuan, Wu, Min-You, Yu, Chia-Ying, Chen, Sung-Lang, Sung, Wen-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392848/
https://www.ncbi.nlm.nih.gov/pubmed/34439091
http://dx.doi.org/10.3390/cancers13163933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392848/
https://www.ncbi.nlm.nih.gov/pubmed/34439091
http://dx.doi.org/10.3390/cancers13163933

Ejemplares similares